Valeant says CEO Pearson to step down, names Ackman to board
(Reuters) - Embattled Canadian drugmaker Valeant Pharmaceuticals International Inc said on Monday Chief Executive Michael Pearson would step down and that the company had appointed activist investor William Ackman to its board.
No comments:
Post a Comment